Peter Cicala's most recent trade in Eterna Therapeutics Inc was a trade of 51,485 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Eterna Therapeutics Inc | Peter Cicala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 51,485 | 51,485 | - | - | Stock Option (Right to buy) | |
Eterna Therapeutics Inc | Peter Cicala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 88,946 | 88,946 | - | - | Stock Option (Right to buy) |